Literature DB >> 10862047

Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development.

J Haines1, R Dunford, J Moody, M Ellender, R Cox, A Silver.   

Abstract

Min (multiple intestinal neoplasia) mice carry a mutant allele of the murine Apc (adenomatous polyposis coli) locus and are predisposed to intestinal adenoma formation in the intestinal tract. Early studies have shown complete loss of function of Apc by whole chromosome loss on the tumor-sensitive C57BL/6J genetic background and in AKR x B6 F1 hybrids. Gamma-radiation-induced chromosomal losses focus the critical region on wt Apc, but because of the limited number of polymorphic markers used, no other critical regions of loss on chromosome 18 were identified. Using intestinal tumors arising spontaneously and induced by X-rays in CBA/H x C57BL/6J F1 hybrid mice and high-resolution microsatellite loss of heterozygosity (LOH) techniques, we provide mapping data for wt Apc loss, which confirms and extends earlier observations. In addition, high-frequency loss events at the Dpc4 locus were found in both spontaneous and radiation-induced tumors. These data identified LOH of Dpc4 as a critical secondary event following complete functional loss of Apc. LOH across the Trp53 genomic region of chromosome 11 was not observed. No LOH was recorded for the Mom1 candidate gene Pla2g2a or for 9 out of 10 polymorphic markers from the Mom1 genomic region on murine chromosome 4. One marker mapping distal to Pla2g2a showed LOH in a small minority of spontaneous tumors. These data support the contention that Mom1 does not act as a classical tumor suppressor. Overall, our data indicates a significant role for Dpc4 mutation in intestinal tumor progression in the mouse and provides further evidence for the importance of interstitial chromosome losses in radiation tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862047     DOI: 10.1002/1098-2264(200008)28:4<387::aid-gcc4>3.0.co;2-h

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Enhanced intestinal tumor multiplicity and grade in vivo after HZE exposure: mouse models for space radiation risk estimates.

Authors:  Daniela Trani; Kamal Datta; Kathryn Doiron; Bhaskar Kallakury; Albert J Fornace
Journal:  Radiat Environ Biophys       Date:  2010-05-20       Impact factor: 1.925

2.  Small Incision Femtosecond Laser-assisted X-ray-irradiated Corneal Intrastromal Xenotransplantation in Rhesus Monkeys: A Preliminary Study.

Authors:  He Jin; Liangping Liu; Hui Ding; Miao He; Chi Zhang; Xingwu Zhong
Journal:  Curr Mol Med       Date:  2018       Impact factor: 2.222

3.  Interstitial chromosomal deletion of the tuberous sclerosis complex 2 locus is a signature for radiation-associated renal tumors in Eker rats.

Authors:  Tatsuya Inoue; Toshiaki Kokubo; Kazuhiro Daino; Hiromi Yanagihara; Fumiko Watanabe; Chizuru Tsuruoka; Yoshiko Amasaki; Takamitsu Morioka; Shino Homma-Takeda; Toshiyuki Kobayashi; Okio Hino; Yoshiya Shimada; Shizuko Kakinuma
Journal:  Cancer Sci       Date:  2020-02-03       Impact factor: 6.716

4.  Heavy ion radiation exposure triggered higher intestinal tumor frequency and greater β-catenin activation than γ radiation in APC(Min/+) mice.

Authors:  Kamal Datta; Shubhankar Suman; Bhaskar V S Kallakury; Albert J Fornace
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

5.  Cancer-preventive Properties of an Anthocyanin-enriched Sweet Potato in the APCMIN Mouse Model.

Authors:  Khalid Asadi; Lynnette R Ferguson; Martin Philpott; Nishi Karunasinghe
Journal:  J Cancer Prev       Date:  2017-09-30

6.  Genotoxic effects of high dose rate X-ray and low dose rate gamma radiation in ApcMin/+ mice.

Authors:  Anne Graupner; Dag M Eide; Dag A Brede; Michele Ellender; Elisabeth Lindbo Hansen; Deborah H Oughton; Simon D Bouffler; Gunnar Brunborg; Ann Karin Olsen
Journal:  Environ Mol Mutagen       Date:  2017-08-30       Impact factor: 3.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.